SCAPINELLO, GRETA
 Distribuzione geografica
Continente #
NA - Nord America 565
EU - Europa 137
AS - Asia 118
OC - Oceania 3
SA - Sud America 1
Totale 824
Nazione #
US - Stati Uniti d'America 564
IT - Italia 81
SG - Singapore 55
CN - Cina 51
FI - Finlandia 13
FR - Francia 11
IN - India 8
NL - Olanda 8
DE - Germania 7
GB - Regno Unito 7
SE - Svezia 5
AU - Australia 2
RU - Federazione Russa 2
TR - Turchia 2
CA - Canada 1
HK - Hong Kong 1
IE - Irlanda 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
Totale 824
Città #
Fairfield 102
Chandler 73
Ashburn 50
Singapore 45
Woodbridge 37
Houston 32
Santa Clara 31
Cambridge 28
Seattle 28
Padova 25
Wilmington 20
Boardman 18
Helsinki 12
Ann Arbor 11
Beijing 9
Medford 9
Princeton 9
San Diego 9
Des Moines 6
Guangzhou 6
Pune 6
Bologna 4
New York 4
Pignone 4
Shanghai 4
Amsterdam 3
Nanjing 3
Verona 3
Boston 2
Castelfranco Veneto 2
Forlì 2
Lucknow 2
Noale 2
Ogden 2
Paris 2
Roxbury 2
Southwark 2
Sydney 2
Thiene 2
Adria 1
Arezzo 1
Caldiero 1
Cittadella 1
Cornedo Vicentino 1
Curtarolo 1
Dublin 1
Forest City 1
Hong Kong 1
Istanbul 1
Kilburn 1
Lappeenranta 1
Lima 1
London 1
Lower Saxony 1
Luxembourg 1
Merkez 1
New Plymouth 1
Phoenix 1
Pisa 1
Portland 1
Prescot 1
Prineville 1
Quezon City 1
Redwood City 1
Rosà 1
Selvazzano Dentro 1
Shenyang 1
Toronto 1
Treviso 1
Trieste 1
Totale 644
Nome #
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine 111
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 100
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 94
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma 71
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib 66
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 61
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients 53
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia 51
Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia 39
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma 35
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 34
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma 31
Rituximab and bendamustine (Br) compared with rituximab, bendamustine, and cytarabine (r-bac) in previously untreated elderly patients with mantle cell lymphoma 30
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 29
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario 21
Clinico-pathological and biological characterization of a cohort of 140 patients affected by relapsed/refractory Diffuse Large B Cell Lymphoma: looking for prognostic factors. 14
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience 10
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 1
CD23 expression in lymphoplasmacytic lymphoma: Clinical–pathological and biological correlations 1
Totale 852
Categoria #
all - tutte 5.202
article - articoli 5.159
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 4 6 7 9 3 4 8
2020/2021115 9 7 6 33 3 4 8 12 15 3 12 3
2021/2022167 2 3 8 12 29 3 14 34 21 0 8 33
2022/2023151 24 13 8 21 28 15 0 3 23 2 5 9
2023/2024143 6 9 15 11 20 19 12 8 4 14 13 12
2024/2025184 3 42 31 29 54 25 0 0 0 0 0 0
Totale 852